- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: COVID vaccine evading variant is here.
Posted on 10/26/21 at 6:12 pm to GumboPot
Posted on 10/26/21 at 6:12 pm to GumboPot
I did the work and read the paper. On reading the paper, it's not as alarmist as the guy is suggesting.
The paper itself noted that a heterologous treatment would possibly offer robust protection against the A.30 variant. The paper also doesn't offer any data on whether the A.30 variant spreads easily - if it has a low R rate, it's nothing to be concerned about. If the variant has a high R rate, then there's something to be concerned about. At this point though, it's nothing to be alarmed about and the paper notes that there have been other variants that are also fairly resistant (and haven't caused any problems so far).
Good read but I wouldn't be that alarmist. As someone noted above, A.30 hasn't been a big problem so far and it's been around for some time now. Neither have the other variants mentioned in the paper.
Paper here if anyone wants to read it
The paper itself noted that a heterologous treatment would possibly offer robust protection against the A.30 variant. The paper also doesn't offer any data on whether the A.30 variant spreads easily - if it has a low R rate, it's nothing to be concerned about. If the variant has a high R rate, then there's something to be concerned about. At this point though, it's nothing to be alarmed about and the paper notes that there have been other variants that are also fairly resistant (and haven't caused any problems so far).
quote:
heterologous ChAdOx1 nCoV-19/BNT162b2 vaccination, which was previously shown to augment neutralizing antibody responses against VOCs compared to corresponding homologous vaccinations [7, 10], might offer robust protection against the A.30 variant
Good read but I wouldn't be that alarmist. As someone noted above, A.30 hasn't been a big problem so far and it's been around for some time now. Neither have the other variants mentioned in the paper.
Paper here if anyone wants to read it
This post was edited on 10/26/21 at 6:14 pm
2
Posted on 10/26/21 at 6:20 pm to AmericanPsycho99
quote:
A.30 variant spreads easily - if it has a low R rate, it's nothing to be concerned about.
You realize that low R rate viruses tend to be more deadly, right?
Meaning the chances of becoming infected are low but the chances of dying are higher.
That’s just the nature of all viruses.
Posted on 10/26/21 at 6:51 pm to AmericanPsycho99
quote:
I did the work and read the paper. On reading the paper, it's not as alarmist as the guy is suggesting.
Of course
He selectively used the scary part in his post
Page 1 of 1
Popular
Back to top
Follow TigerDroppings for LSU Football News